SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-245344
Filing Date
2021-08-13
Accepted
2021-08-13 07:00:58
Documents
14
Period of Report
2021-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d367643d8k.htm   iXBRL 8-K 25875
2 EX-99.1 d367643dex991.htm EX-99.1 21002
6 GRAPHIC g367643dsp04.jpg GRAPHIC 8752
  Complete submission text file 0001193125-21-245344.txt   188493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hcwb-20210813.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hcwb-20210813_lab.xml EX-101.LAB 18122
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hcwb-20210813_pre.xml EX-101.PRE 11420
7 EXTRACTED XBRL INSTANCE DOCUMENT d367643d8k_htm.xml XML 3321
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 211169681
SIC: 2834 Pharmaceutical Preparations